|
Real-time Estimate
Cboe BZX
23:55:44 27/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 9.860 USD | +0.31% |
|
+2.17% | +26.54% |
| 08-25 | BioCryst Pharmaceuticals Announces Approval Of ORLADEYO For Pediatric HAE Patients In Japan | CI |
| 08-25 | BioCryst Pharmaceuticals Gets Japan Approval for Orladeyo in Young Children | MT |
Stock exchange
Nasdaq
BCRX 9.865 $
+0.36%
16.82M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| BCRX | 9.865USD | +0.36% | 16.82M $ | ||
CBOE
| BCRX | 9.895USD | +0.66% | 932K $ | |
|
Boerse Muenchen
| BO1 | 8.454EUR | +0.28% | 2.37K € | |
|
Mexican S.E.
| BCRX * | 182.00MXN | -6.67% | 18.2K $ | |
|
Tradegate
| BO1 | 8.526EUR | +1.11% | 102.31 € | |
|
Deutsche Boerse AG
| BO1 | 8.350EUR | +0.22% | 0 € | |
|
Börse Stuttgart
| BO1 | 8.450EUR | +0.21% | 0 € | |
|
Berne S.E.
| BO1 | 7.908CHF | +0.85% | 0 CHF |
Quotes 5-day view: BioCryst Pharmaceuticals, Inc.
Delayed Quote Nasdaq
| 21/08/2026 | 24/08/2026 | 25/08/2026 | 26/08/2026 | 27/08/2026 | |
|---|---|---|---|---|---|
| Last | $9.550 | $9.680 | $9.830 | $9.830 | $9.865 |
| Volume | 2,496,708 | 2,010,324 | 2,332,655 | 1,858,895 | 1,705,341 |
| Change | -1.14% | +1.36% | +1.55% | 0.00% | +0.31% |
| Opening | $9.720 | $9.500 | $9.790 | $9.770 | $9.750 |
| High | $9.905 | $9.755 | $9.916 | $9.900 | $9.885 |
| Low | $9.480 | $9.480 | $9.698 | $9.710 | $9.551 |
Performance
| 1 day | +0.41% | ||
| 1 week | +2.17% | ||
| Current month | +9.91% | ||
| 1 month | +3.03% | ||
| 3 months | +8.22% | ||
| 6 months | +12.80% | ||
| Current year | +26.54% | ||
| 1 year | +15.85% | ||
| 3 years | +35.76% | ||
| 5 years | -36.97% | ||
| 10 years | +137.83% |
Volumes
marketsDaily volume
1,705,341
Estimated daily volume
1,794,047
Avg. Volume 20 sessions
3,477,525
Daily volume ratio
0.52
Avg. Volume 20 sessions USD
34,288,396.5
Record volume 1
40,095,470
Record volume 2
37,550,050
Record volume 3
37,366,410
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
2,511,910,082
Net sales (USD)
874,837,000
Number of employees
435
Sales / Employee (USD)
2,011,120
Free-Float
94.77 %
Free-Float capitalization (USD)
2,380,555,144
Average Daily Capital Traded
1.37%
Indicators
Moving average 5 days
9.758
Moving average 20 days
9.604
Moving average 50 days
9.646
Moving average 100 days
9.298
Price spread / (MMA5)
-1.03%
Price spread / (MMA20)
-2.60%
Price spread / (MMA50)
-2.17%
Price spread / (MMA100)
-5.70%
STIM
RSI 9 days
52.96
RSI 14 days
52.61
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.31% | +2.17% | +15.85% | +35.76% | 2.51B | |
| +3.31% | -3.70% | +61.03% | +103.64% | 70.42B | |
| +1.09% | +3.40% | +51.59% | +93.39% | 65.4B | |
| -1.17% | +0.48% | +8.16% | -7.67% | 28.28B | |
| -0.49% | +5.43% | +54.81% | +13.87% | 26.57B | |
| -2.42% | -2.12% | -8.99% | +466.28% | 27.16B | |
| +0.37% | +1.21% | +36.55% | -17.60% | 20.09B | |
| +1.02% | +6.43% | +269.42% | +420.34% | 20.61B | |
| +0.77% | +0.19% | +8.01% | +520.34% | 15.87B | |
| -1.44% | +2.70% | +43.18% | +148.60% | 13.9B | |
| Average | +0.15% | +1.18% | +53.96% | +177.70% | 29.08B | |
| Weighted average by Cap. | +0.74% | +0.73% | +55.60% | +154.56% |
Historical Quotes: BioCryst Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
6b1206633bdf6f2891.Meoz-9EpNON0bJfchdFi5zVbLVTGjli1Wq6O0c5FxVE.RccDopcZXNoQVM-F8-MRoAV2eB2fxTuAC8L9q5Q29ilWunKZtnp6qxguwg
| Date | Price | Volume | Total |
|---|---|---|---|
| 23:40:41 | 9.865 | 100 | 1,444,389 |
| 23:40:38 | 9.865 | 200 | 1,444,289 |
| 23:40:13 | 9.865 | 100 | 1,444,089 |
| 23:39:42 | 9.865 | 100 | 1,443,989 |
| 23:38:47 | 9.870 | 100 | 1,443,889 |
| 23:38:47 | 9.875 | 100 | 1,443,789 |
| 23:38:39 | 9.875 | 100 | 1,443,689 |
| 23:38:35 | 9.875 | 200 | 1,443,589 |
| 23:38:32 | 9.875 | 190 | 1,443,389 |
| 23:38:22 | 9.875 | 148 | 1,443,199 |
Price Extremes
| 1 week | 9.48 |  | 9.92 |
| 1 month | 8.76 | | 10.68 |
| Current year | 6.23 | | 11.22 |
| 1 year | 6 | | 11.22 |
| 3 years | 4.03 | | 11.31 |
| 5 years | 4.03 | | 19.99 |
| 10 years | 1.38 | | 19.99 |
Monthly variations
Annual variations
| 2026 | +26.03% | ||
| 2025 | +3.72% | ||
| 2024 | +25.54% | ||
| 2023 | -47.82% | ||
| 2022 | -17.11% | ||
| 2021 | +85.91% | ||
| 2020 | +115.94% | ||
| 2019 | -57.25% | ||
| 2018 | +64.36% | ||
| 2017 | -22.43% | ||
| 2016 | -38.66% | ||
| 2015 | -15.13% | ||
| 2014 | +60.00% | ||
| 2013 | +435.21% | ||
| 2012 | -42.51% | ||
| 2011 | -52.22% | ||
| 2010 | -19.97% | ||
| 2009 | +371.53% | ||
| 2008 | -77.83% | ||
| 2007 | -46.54% | ||
| 2006 | -30.99% | ||
| 2005 | +189.79% | ||
| 2004 | -15.62% | ||
| 2003 | +613.54% | ||
| 2002 | -75.76% | ||
| 2001 | -40.23% | ||
| 2000 | -77.54% | ||
| 1999 | +321.43% | ||
| 1998 | 0.00% | ||
| 1997 | -57.25% | ||
| 1996 | +77.03% | ||
| 1995 | +100.00% | ||
| 1994 | -28.85% |
- Stock Market
- Stocks
- BCRX Stock
- Quotes BioCryst Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
